It has previously been reported that amyloid-b (Ab) peptide is neurotrophic to undifferentiated but neurotoxic to differentiated primary neurons. The underlying reasons for this differential effect is not understood. Recently, the toxicity of Ab to neurons was shown to be dependent upon the activation of cyclindependent kinase 5 (Cdk5), thought to promote tau phosphorylation that leads to cytoskeletal disruption, morphological degeneration and apoptosis. Here we report that Cdk5, tau, and phosphorylated-tau (P-tau) are expressed at very low levels in undifferentiated primary neurons, but that the expression of Cdk5 and tau and the phosphorylation of tau increase markedly between 4 and 8 days of differentiation in vitro. Tau expression decreased after this time, as did the level of P-tau, to low levels by 17 days. Ab induced tau phosphorylation of neurons only after ‡ 4 days of differentiation, a time that coincides with the onset of Ab toxicity. Blocking tau expression (and therefore tau phosphorylation) with an antisense oligonucleotide completely blocked Ab toxicity of differentiated primary neurons, thereby confirming that tau was essential for mediating Ab toxicity. Our results demonstrate that differentiation-associated changes in tau and Cdk-5 modulate the toxicity of Ab and explain the opposite responses of differentiated and undifferentiated neurons to Ab. Our results predict that only cells containing appreciable levels of tau are susceptible to Ab-induced toxicity and may explain why Ab is more toxic to neurons compared with other cell types.
Alzheimer's disease (AD) neuropathology is characterized by the intracellular accumulation of neurofibrillary tangles (NFT) and the extracellular deposition of senile plaques. NFTs are composed primarily of highly phosphorylated tau in paired helical filaments (PHF) whereas senile plaques are composed primarily of fibrillar amyloid-b (Ab; Glenner et al. 1984; Masters et al. 1985; Alvarez et al. 1999) . Ab is a 39-42 amino acid protein derived from the amyloid-b precursor protein (AbPP) via proteolytic cleavage at the b-and c-secretase cleavage sites.
The physiological function of Ab, and its role in AD, remains unclear. Early studies in primary cell culture indicated that Ab was neurotrophic to undifferentiated hippocampal neurons at low concentration but neurotoxic to mature differentiated neurons at higher concentration (Whitson et al. 1989 (Whitson et al. , 1990 Yankner et al. 1990; Kaltschmidt et al. 1999) . In addition, we have shown that nanomolar concentrations of Ab are anti-apoptotic to undifferentiated E18 rat neurons following trophic factor withdrawal (Chan et al. 1999) , suggesting Ab also has neuroprotective properties. These protective properties appear to be related to the protein's metal ion binding and redox/antioxidant capacity (Atwood et al. 1998 Bush et al. 1999; Chan et al. 1999; Kontush et al. 2001; Zou et al. 2002) . Conversely, these same redox properties can promote Ab toxicity at higher concentrations of Ab (Cuajungco et al. 2000; Sponne et al. 2003) .
Ab has been shown to exert its neurotoxicity through a mechanism that induces intracellular generation of O À Á 2 / H 2 O 2 (Behl et al. 1994) , lipid peroxidation (Mark et al. 1997; Rottkamp et al. 2001; Wei et al. 2002) , calcium ion accumulation (Mattson et al. 1992) , activation of c-Jun N-terminal kinase (JNK) (Wei et al. 2002) and subsequent neuronal or vascular endothelial cell death (Behl et al. 1994; Hensley et al. 1995; Thomas et al. 1996) . Recently, the downstream mechanism of Abinduced toxicity has been linked to phosphorylated-tau (P-tau: Patrick et al. 1999; Zhang and Johnson 2000) and the disruption of microtubule networks (Sponne et al. 2003) , characteristic changes evident as NFTs in vulnerable neurons of the AD brain. This mechanism involves Ab-induced Ca(II) accumulation (Mattson et al. 1992 ) that activates calpain and subsequently the cleavage of p35 to p25 Patzke and Tsai 2002; Town et al. 2002) . p25 then binds with high affinity to cyclin-dependent kinase 5 (Cdk5), a small serine/threonine kinase and constitutively activates it, causing the hyperphosphorylation of tau that is thought to promote disruption of microtubules, collapse of the cytoskeleton and cell death (Patrick et al. 1999; Lee et al. 2000; Zhang and Johnson 2000; Alvarez et al. 2001; Town et al. 2002) . That these pathways are involved in Ab-induced toxicity is confirmed by the fact that blockage of any causative or signaling component of this pathway provides neuroprotection. For example, Ab neurotoxicity can be abolished by the presence of superoxide dismutase (Thomas et al. 1996) , catalytic synthetic O À Á 2 /H 2 O 2 scavengers (Gsell et al. 1995) , the spin-trap compound phenyl-N-tert-butyl-nitrone (Butterfield et al. 1996) , or chainbreaking antioxidants, such as vitamin E or vitamin C (Mattson and Goodman 1995; Mark et al. 1996 Mark et al. , 1997 Markesbery 1997; Varadarajan et al. 2000) . Likewise, the Cdk5 inhibitor butyrolactone I, and a Cdk5 antisense probe, markedly decrease Ab-induced death of rat hippocampal neurons (Alvarez et al. 1999) , indicating that inhibition of tau phosphorylation prevents Ab-induced neuronal death. Importantly, neurons from tau knockout mice are resistant to Ab toxicity (Rapoport et al. 2002) , indicating a key role for tau in the mechanisms leading to Ab-induced neurodegeneration in the central nervous system. Likewise, Ab-induced JNK activation and cell death are inhibited by overexpression of a dominant-negative stress-activated protein kinase kinase-1 (SEK1-AL) construct (Wei et al. 2002) , an upstream signaling member of the JNK pathway. Butyrolactone I, a Cdk5 inhibitor, provided additional protection against Ab toxicity in SEK1-AL-expressing cells, suggesting that Cdk5 and JNK activation independently contributed to this toxicity. Blockade of either calpain or Ca(II) channels also opposes p35-dependent tau phosphorylation induced by soluble Ab (Town et al. 2002) . The relevance of this mechanism to AD is shown by the fact that p25 accumulates in neurons (Patrick et al. 1999) and that there is persistent activation of Cdk5 in the brains of patients with AD (Iijima et al. 2000) . Indeed, mice overexpressing AbPP have recently been shown to have increased p25 levels and display hyperphosphorylated tau in and around amyloid deposits (Otth et al. 2002) .
Since Ab is toxic to differentiated neurons, but not toxic to undifferentiated neurons, we hypothesized that the increased expression of components of the tau phosphorylation pathway during differentiation is critical to Ab toxicity. We show for the first time that Ab toxicity is modulated by differentiation-associated increases in tau and Cdk5 expression in rat primary neurons. These results indicate that Ab is toxic only to differentiated neurons.
Materials and methods

Reagents
Human Ab1-40 was synthesized and purified by HPLC and characterized by amino acid analysis and mass spectroscopy by W.M. Keck Foundation Biotechnology Resource Laboratory (Yale University, New Haven, CT, USA). The peptide was identified as a single peak upon HPLC and showed no chemical modification.
Tau sense and antisense oligonucleotides were obtained from IDT (Coralville, IA, USA). The tau antisense oligonucleotide sequence was 5¢-G*T*T*CAGCCATGCTGCTTCAAAGC*C* T*G-3¢ (* indicates phosphorothioate bond), which corresponds to nucleotide )16 to +10 in the rat tau gene sequence (Pizzi et al. 1994) . Sense oligonucleotide was the reverse complement of the antisense.
Rat (E18) primary cortical neurons were purchased from BrainBits (Dr Gregory Brewer at Southern Illinois University School of Medicine, Springfield, IL, USA). MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] was purchased from Sigma (Saint Louis, MO, USA). Neurobasal medium without phenol red, B27, and glutamine were purchased from Invitrogen (Carlsbad, CA, USA). AT8 mouse anti-human PHF-Tau monoclonal antibody was purchased from Endogene (Woburn, MA, USA) and recognizes tau protein phosphorylated at both serine 202 and threonine 205 (Goedert et al. 1995) ; rabbit polyclonal antisera against (Perry et al. 1991) . Cdk5 rabbit polyclonal antibody was obtained from StressGen Biotechnologies Corporation (Victoria, Canada) and recognizes the C-terminus of Cdk5. All other reagents were analytical grade or purer.
Primary rat cortical neuron culture Neuronal cultures were taken from frontal cortices of SpragueDawley rat embryonic (E18) pups. The cells were dissociated by trituration in Hibernate E media (Brainbits, Southern Illinois University School of Medicine, Springfield, IL, USA), undispersed tissue allowed to settle for 1 min, and the supernatant transferred to a new tube prior to centrifugation for 1 min at 200 g. The supernatant was then removed and the cells resuspended in serumfree Neurobasal medium (without phenol red) with B-27 supplement (Life Technologies, Inc., Rockville, MD, USA), 25 lM L-glutamate, 100 U/mL penicillin, 100 lg/mL streptomycin, and 0.5 mM L-glutamine, counted using a hemocytometer and then equal volumes of mixed cells were plated into 6-well (1 · 10 6 cells/well) or 96-well (2 · 10 4 cells/well) poly-L-lysine-coated plates (BD Biosciences, Bedford, MA, USA). Cortical cultures were grown in 5% CO 2 , 85% humidity in the above media. On the fourth day, the medium was replaced with the same media without L-glutamate and changed every 2-3 days. In cultures treated with Ab, Ab1-40 was filter sterilized prior to addition to the media at a concentration of 1 lM or 10 lM. The media of neurons treated with sense or antisense oligonucleotides (5 lM each) were changed daily. Experimental trials were performed in 6-9 replicate wells.
Amyloid-b preparation
Synthetic Ab peptide was dissolved in sterile doubly deionized water at a concentration of 0.5-1.0 mg/mL, passed through a 0.22 lm filter (Millipore, Bedford, MA, USA) and the concentration determined by spectrophotometric absorbance at 214 nm. Peptide solutions were then incubated at 37°C for 4 days to fibrillize Ab (modified from Wei et al. 2002) .
Cell viability
Cell viability was assessed using the MTT assay. This assay is based on the cleavage of the yellow tetrazolium salt MTT to purple formazan crystals by metabolically active cells. Briefly, neurons (and blank wells) were incubated with media (100 lL) containing 1.2 mM MTT for 4 h at 37°C. Following this, a 10% sodium dodecyl sulfate solution in 0.01 M HCl (100 lL) was added to the wells for a further 4 h at 37°C in a humidified chamber and the optical density was then read at 570 nm by using a Spectramax 190 spectrophotometer (Molecular Devices, Sunnyvale, CA, USA).
Sample collection and immunoblot analyses
Neurons were collected into sample buffer (20 mM Tris-HCl, pH 7.6, 150 mM NaCl, 1 mM EDTA, 1 mM EGTA, 1% sodium dodecyl sulfate containing protease inhibitors: 1 mM phenylmethylsulfonyl fluoride; 10 lg/ml aprotinin; 10 lg/mL leupeptins; 1 lg/mL pepstatin A). The protein concentration of samples was determined by using the BCA Protein Assay kit (Pierce, Rockford, IL, USA). Samples containing equal cell numbers (with roughly similar protein concentrations) were loaded, since the expression of traditional proteins used to control for loading, such as tubulin and actin, increases with differentiation (Drubin et al. 1988) . Loaded samples were run on sodium dodecyl sulfate-polyacrylamide gel electrophoresis gels (Tricine gels, 10-20%; Novex, San Diego, CA, USA), transferred to PVDF membranes (Bio-Rad Laboratories, Hercules, CA, USA), fixed with glutaraldehyde (1%, v/v), blocked with milk (10%, w/v) and then probed with primary antibody overnight at 4°C. 
Results
Amyloid-b is non-toxic to undifferentiated primary cortical neurons Differentiation of primary neurons is seen by extensive neurite outgrowth and the up-regulation of microtubuleassociated proteins over the first few days in culture (Drewes et al. 1992; Bramblett et al. 1993; Goedert et al. 1994 ). Ab1-40 added to rat cortical primary neurons has been reported to significantly increase neuronal survival during the first 24 h of culture. This trophic effect became progressively less apparent when Ab1-40 was added after 2 days of culture and was toxic after 3 days of culture (Yankner et al. 1990) . To confirm the trophic properties of Ab1-40 on undifferentiated neurons (Whitson et al. 1989; Yankner et al. 1990; Chan et al. 1999) , primary rat cortical neurons cultured for 2 days were exposed to 0 or 10 lM Ab1-40 and viability measured after 48 h. The viability of the treated and untreated neurons was not significantly different (Fig. 1a) . To confirm the toxic properties of Ab1-40 on neurons that were more differentiated, primary rat cortical neurons cultured for 8 days were exposed to 0 or 10 lM Ab1-40 and viability measured. As previously reported, by 24 h, the viability of treated differentiated neurons (46%) was significantly lower than that of untreated neurons (Fig. 1b) .
Since it has been reported that Ab may interfere with the MTT assay (Liu and Schubert 1997) , primary neurons cultured for 10 days were incubated with 0, 1 or 10 lM Ab1-40 for 2 days. Viability was then either measured immediately using the MTT assay or the media containing Ab1-40 replaced with media containing no Ab1-40 for 2 days (to allow time for Ab clearance; Farris et al. 2003) before the viability was determined using the MTT assay. No significant difference in viability was detected between these two treatments at 1 lM Ab1-40 (71.1 ± 9.6% vs. 70.5 ± 11.7%, n ¼ 6) or 10 lM (52.6 ± 6.0% vs. 53.9 ± 8.8%, n ¼ 6), indicating that Ab1-40 was not interfering with MTT exocytosis and reduction.
P-tau levels increase with Ab treatment
Since tau phosphorylation promotes microtubule disruption and neuronal death, we tested to determine if Ab induced tau phosphorylation. Cells cultured for 1, 2 and 3 days were then treated for 25 h (i.e. $ 2, 3 and 4 days in culture) with and without Ab (10 lM) and the level of P-tau determined. No difference in the level of P-tau isoforms (43-61 kDa) was observed between treated and untreated neurons at 2 days (P-tau/actin ratio ¼ 0.9 and 1.0, respectively) and 3 days (P-tau/actin ratio ¼ 4.5 and 4.5, respectively) of culture, but an increase in the phosphorylation of these isoforms was observed following 4 days of treatment with Ab1-40 (P-tau/ actin ratio ¼ 6.0 and 9.6, respectively; Fig. 2 ). Similar results have been reported in primary cells and cell lines (Greenberg et al. 1994; . These results suggest a change associated with differentiation between 3 and 4 days of culture that allows for the increased phosphorylation of tau.
Tau and Cdk5 expression change with differentiation To determine if changes in the expression of tau or Cdk5 during differentiation could explain the increase in tau phosphorylation following Ab treatment, we measured tau and Cdk5 expression changes during the differentiation of E18 primary rat cortical neurons grown in 6-well plates for 1, 4, 8, 10, 14 and 17 days. Morphological changes such as progressive neurite extension were observed consistent with differentiation of these neurons (data not shown). Immunoblot analyses indicated an approximately three-fold increase in the concentration of the 43-61 kDa isoforms of tau between 1 and 4 days that further increased to seven-fold by 8 days (Fig. 3) . After 8 days, the concentration of these tau isoforms decreased through to 17 days while the concentration of a higher molecular weight tau isoform ($120 kDa) progressively increased ($30-fold) in intensity through to 17 days. These results indicate an increase in the cellular concentration of both low-and high-molecular weight tau isoforms during cortical neuron differentiation. The expression of Cdk5 also increased, by five-fold between 4 days to 8 days and continued to increase until 10 days (13-fold) after which it plateaued to 17 days of culture (Fig. 3) . The 43-61 kDa isoforms of tau displayed increased phosphorylation in parallel with their expression, increasing 48-fold to 10 days and thereafter decreasing to low levels by 17 days of culture. The maintenance of Cdk5 expression after 10 days but the decline of tau phosphorylation suggests that phosphorylation was more dependent upon the level of tau expression (or Cdk5 activity) after 10 days rather than the level of Cdk5 expression. No phosphorylation of the higher molecular weight isoform of tau was observed.
Tau antisense oligonucleotide blocks Ab-induced toxicity
To confirm that increases in cellular tau were responsible for mediating the toxicity of Ab, primary neurons grown for 1 day were then treated with an antisense or sense tau oligonucleotide to block tau expression. Treatment with the tau antisense oligonucleotide for 5 days, but not sense oligonucleotide, markedly decreased the expression of tau (81% vs. 20%, respectively) compared to untreated neurons (Fig. 4a) . When these cultures treated with antisense oligonucleotide were exposed to Ab1-40 for 24 h, there was a significant dose-dependent increase in MTT signal, indicating that Ab1-40 was neurotrophic to tau-deficient neurons (Fig. 4b) . Conversely, when these cultures treated with sense oligonucleotide were exposed to Ab1-40 for 24 h, there was a significant decrease in MTT signal at 10 lM Ab1-40. The lower Ab1-40-induced toxicity of the sense-treated neurons (19%; Fig. 4b ) compared with our previous experiment Fig. 2 Ab-induced tau phosphorylation is dependent upon differentiation. Neurons were differentiated for 1, 2 or 3 days and then exposed to 0 or 10 lM Ab1-40 for 25 h and the levels of tau phosphorylation determined using the AT8 mouse anti-human PHF-Tau monoclonal antibody.
(48%; Fig. 1b) is consistent with the shorter time period of differentiation of the neurons in these experiments (6 days vs. 8 days in Fig. 1b) . In all our experiments, Ab1-40 was toxic to neurons cultured for greater than or equal to 4 days, and toxicity increased as a function of time in culture (i.e. differentiation). Taken together, these results indicate that Ab1-40 is toxic to neurons once tau reaches a critical threshold level.
Discussion
These results demonstrate that differentiation-associated changes in cellular tau (and Cdk5) regulate the viability of cortical neurons to Ab (Figs 1-4) . Ab1-40 was toxic only to primary neurons containing high concentrations of tau, but not toxic or neurotrophic to primary neurons containing low concentrations of tau (Figs 1, 2 and 4) . Our results confirm and explain why in previous studies Ab was neurotrophic to undifferentiated neurons but toxic to more differentiated neurons (Whitson et al. 1989 (Whitson et al. , 1990 Yankner et al. 1990; Behl et al. 1992 ).
The microtubule-associated protein (MAP) tau is mainly found in the brain and spinal cord, but is also found at relatively high levels in heart, skeletal muscle, lung, kidney and testis and at much lower levels in adrenal gland, stomach, liver, spleen and fibroblasts (Montejo et al. 1986; Tucker 1990; Ashman et al. 1992; Lee and Rook 1992; Lubke et al. 1994; Matsuyama and Bondareff 1994; Gu et al. 1996) . Tau is highly enriched in axonal compartments (especially in mature neurons; Fig. 3 ) but is not present in microglia (Binder et al. 1985; Trojanowski et al. 1989) . Interestingly, tissues with high levels of cellular tau (i.e. brain and muscle) are the only reported tissues that accumulate Ab (Glenner and Wong 1984; Masters et al. 1985; Kuo et al. 2000) and display cell loss (Murakami et al. 1995a,b; Gomez-Isla et al. 1996 , 1997 . Our results may explain why glia (Binder et al. 1985; Trojanowski et al. 1989 ) with low concentrations of cellular tau is more resistant to Ab toxicity (DeWitt et al. 1998; Casal et al. 2002) . Our results would further predict that only those cell types that contain appreciable levels of tau, and Cdk5 activity, would be susceptible to Ab-induced toxicity. That astrocytes have been reported to contain tau (Papasozomenos and Binder 1987; Papasozomenos 1989) but are not susceptible to Ab-induced toxicity (Kerokoski et al. 2001; Malchiodi-Albedi et al. 2001) suggests they may contain low Cdk5 activity (Tsai et al. 1993; Nikolic et al. 1996) .
Division competent cells (such as microglia) that do not contain tau may not be as susceptible to Ab-induced toxicity. Conversely, nerve growth factor-induced differentiation of pheochromacytoma (PC12) cells, which induces neurite process formation and parallel increases in the levels of the microtubule-associated proteins, tau, MAP1, and tubulin (Drubin et al. 1988) , greatly potentiates the toxicity of amyloid-b peptides (Behl et al. 1992) .
Previous workers (Alvarez et al. 1999) have shown that tau phosphorylation via the p35/p25/Cdk5 pathway is required for Ab-induced neuron death (Fig. 5) . Indeed, Ab induces Cdk5 activity in rat hippocampal neurons. We show that the expression of Cdk5 increases during differentiation of primary cortical neurons ( Fig. 3 ; Wu et al. 2000) . Given that previous studies have shown Cdk5 inhibitors and Cdk5 antisense prevent hyperphosphorylation and neuronal death (Alvarez et al. 1999; Lee et al. 2000; Town et al. 2002) , it is likely that differentiation-associated increases in tau and the activity of Cdk5/p35 are essential for Ab toxicity of neurons. Interestingly, enzymatically active Cdk5 is only present in neurons (Tsai et al. 1993; Nikolic et al. 1996; Chae et al. 1997) .
Although we and other workers have shown that Ab-induced tau phosphorylation is required for neuron death, an intriguing observation from our present results was that although there was a large increase in P-tau during differentiation, this did not affect the viability of the neurons. Indeed, the increase in tau expression and phosphorylation during differentiation suggests these processes are important for normal neuritic outgrowth that occurs in the first 10 days of culture, whereas the decline in tau expression and phosphorylation after this time suggests lower levels of tau and P-tau are required for the maintenance of formed neurites. Therefore, Ab may induce its toxicity by phosphorylation of amino acids on tau other than those detected with our antibody (phosphorylated serine 202 and threonine 205).
Neuroblastoma cells display low levels of tau phosphorylation during interphase, but tau becomes highly phosphorylated during mitosis (Pope et al. 1994; Illenberger et al. 1998; Preuss and Mandelkow 1998) , as also is seen following Ab treatment (Fig. 2) . That tau is hyperphosphorylated in neurons vulnerable to AD pathology strengthens the argument that there is a reactivation of cell cycle machinery in the AD brain. Intriguingly, Ab-induced tau hyperphosphorylation suggests the real possibility that the accumulation of Ab in the AD brain triggers this aberrant cell cycle activity (Raina et al. 2000) .
Our experiments support the idea that aged (differentiated) neurons are more vulnerable to Ab toxicity. It has been reported that fibrillar Ab injected into aged (25-27 years) monkey cerebral cortex results in tau phosphorylation, neuronal loss and microglial proliferation. However, young monkeys (5 years) were not sensitive to such injections (Geula et al. 1998) , suggesting that the level of tau and/or level or activity of Cdk5 (and regulatory subunit p35) in neurons of these monkeys was insufficient to allow Ab-induced toxicity. This is supported by the finding that tau expression increases from embryonic day 13-14 in rats and is maximal between E20 and P8, corresponding to times of maximal axonal growth, before decreasing to adult levels (Kosik et al. 1989) . Likewise, Cdk5 activity increases with neuronal differentiation (Nikolic et al. 1996; Munoz et al. 2000) between E18 to postnatal day 14 but then decreases in the adult and aged rat brain (Wu et al. 2000) . Moreover, the pattern of p35 and p25 expression and Cdk5 activity correlates well with neuronal death in AD, i.e. they are significantly higher in the cerebral cortex and hippocampus, but lower in the cerebellum and striatum (Patrick et al. 1999; Wu et al. 2000; Tseng et al. 2002) . Future studies will be required to confirm if age-or disease-related changes in cellular tau and activities of Cdk5 or regulatory subunits (p35 and p39) increase the susceptibility of neurons to Ab toxicity in vivo.
Morphological and biochemical changes (Fig. 3 ) that we report in our aging cultured neurons are consistent with differentiation-associated changes previously reported in Neurons were cultured for 1 day and then treated with antisense (5 lM), sense (5 lM) or no treatment for a further 4 days prior to western analyses for tau. (b) Ab1-40 is neurotropic in the absence of tau but toxic in the presence of tau. E18 rat neurons were treated with sense or antisense oligonucleotide or no treatment from day 2 after plating for 4 days and then exposed to fibrillized Ab1-40 (0, 1 or 10 lM) for 24 h. Results are mean ± SD; n ¼ 4-6. differentiating cultured cortical neurons (Drewes et al. 1992; Arioka et al. 1993; Bramblett et al. 1993; Brion et al. 1993; Goedert et al. 1993; Pizzi et al. 1995; Smith et al. 1995) . Neurite outgrowth was associated with an increase in tau isoforms between 43 and 61 kDa (Gu et al. 1996) . A larger tau isoform ($120 kDa), formed by alternative splicing and normally associated with peripheral neurons (Couchie et al. 1992; Goedert et al. 1992 ) and skeletal muscle, heart and adrenal gland (Gu et al. 1996) , increased from day 8 of differentiation (Fig. 3) . The relevance of this larger tau isoform to the differentiation process and whether there are functional differences between isoforms remains to be determined.
Tau's major cellular role is thought to involve regulation of neuronal microtubule assembly and stabilization of microtubules against depolymerization in vivo ( Kanai et al. 1989) . Such a role is supported by the time course of tau expression during process formation where neurite extension is paralleled by an increase in the amount of expressed tau ( Fig. 3 and references above). Gene transfer experiments have shown that the level of expressed tau influences microtubule assembly, neurite outgrowth, and neuritic stability in cultured neural cells (Pelech 1995) . Tau also has been shown to have a binding site for AbPP (Giaccone et al. 1996) suggesting tau may have alternative activities. One such function may involve axonal transport, since tau (and perhaps P-tau) competes with the kinesin/dynesin binding site of microtubules to regulate transport (Stamer et al. 2002) . Although tau antisense experiments have been shown to reduce microtubule levels and slow neurite outgrowth (Esmaeli-Azad et al. 1994 ; data not shown), tau knockout mice appear to be histologically normal and display no phenotype indicating tau is not essential for the development and maintenance of axons (Harada et al. 1994) . Indeed, blocking tau expression with antisense oligonucleotides is unlikely to influence the functional differentiation of primary neurons. The function of tau, other than as a mediator of toxicity, remains to be fully elucidated.
From our results and others, it is apparent that Ab-induced cell death occurs via the calpain/p35/Cdk5/tau phosphorylation pathway (Fig. 5) . The increased expression of proteins in this pathway is positively related to the cellular sensitivity to Ab1-40 toxicity. Whether Ab-induced tau phosphorylation promotes toxicity via microtubule depolymerization or a toxic gain of function via other mechanisms remains to be determined. Nevertheless, redundancies in this cellular signaling pathway that express themselves later in life and lead to tau phosphorylation may promote the neuronal loss and pathology associated with AD.
